[1]
2015. IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer. Swiss Medical Weekly. 145, 5152 (Dec. 2015), w14215. DOI:https://doi.org/10.4414/smw.2015.14215.